MedPath

MENOMUNE-A/C/Y/W-135

MENOMUNE-A/C/Y/W-135

Discontinued
DIN Number

01959018

Drug Class

Human

Market Date

Oct 29, 1993

Company
HC

Sanofi Pasteur Limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number01959018
AIG Number0440084002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J07AH04 MENINGOCOCCUS, A, C, Y, W-135, TETRAVAL. PURIFIED POLYSACC. ANTIGEN
Product Specifications
Dosage FormPowder For Solution ,  Kit
Route of AdministrationSubcutaneous
AHFS Classification80:12.00
Health Canada Classification

ACTIVE INGREDIENTS (4)

MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP AActive
Strength: 50 MCG / 0.5 ML
Monograph: MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP A
MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP CActive
Strength: 50 MCG / 0.5 ML
Monograph: MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP C
MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP W-135Active
Strength: 50 MCG / 0.5 ML
Monograph: MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP W-135
MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP YActive
Strength: 50 MCG / 0.5 ML
Monograph: MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP Y

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.